The Effects of Glucomannan on Weight Loss
Phase 1
Completed
- Conditions
- Obesity
- Interventions
- Dietary Supplement: GlucomannanOther: Placebo
- Registration Number
- NCT01709955
- Lead Sponsor
- Northeast College of Health Sciences
- Brief Summary
The purpose of this study is to determine if the herb, Glucomannan, is an effective non-pharmacological appetite suppressant for overweight or Class I obese patients. The study design will not include any other lifestyle changes which enhance weight loss in order to completely isolate the effects of Glucomannan as a non-pharmacological appetite suppressant.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 43
Inclusion Criteria
Subjects will be recruited based upon the category of them wanting to lose 50 pounds.
Subjects must be able to swallow the capsule whole with water.
Exclusion Criteria
- Self-reported use of prescription medication other than hormonal birth control (such as medication for diabetes, hypertension hypothyroidism, heart disease, cancer, etc.)
- Pregnancy
- Age younger than 21 or older than 60 years of age.
- Screening for hypertension during the first laboratory visit that reveals a systole greater than 120 and a diastole greater than 90.
- BMI calculations based upon height and weight measurements at the first laboratory visit that reveal a BMI less than 25 or greater than 35.
- Self-reported iron-deficiency anemia, osteoporosis, and hypoglycemia.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Gucomannan Glucomannan - Placebo pill Placebo -
- Primary Outcome Measures
Name Time Method Weight Loss 30 Days
- Secondary Outcome Measures
Name Time Method